Stalsberg H. Cervical neoplasia in Pap smears. Risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme International Journal of Epidemiology 1996; 25: 53-58. Background. The aim of this study was to examine, In a population not submitted to mass screening, the risk of cancer and cervical intra-epithelial neoplasia (CIN) in Pap smears from women without previously reported positive smears. Methods. In a logistic regression model consisting of 58 271 smears from 40 536 Norwegian women the risk of cytologically indicated CIN was studied according to age and time elapsed since last smear. Results. The risk of CIN was highest In smears from women with no previously registered smears and in smears taken after an interval of *5 years. Odds ratio for CIN Ml adjusted for age was highest in first time smears and In smears taken after an interval of 5 years. Odds ratio for CIN III was highest In first registered smears. No difference in risk of CIN III was found in smears taken within one year or 2-3 years after the last smear. The increased risk of CIN III In first smears was most pronounced in postmenopausal women (>50 years). Nine of 16 cases with cytological indication of cancer were found in women having a smear taken for the first time. All cases with malignancy In smears were >50 years. Conclusions. The risk of cytologically diagnosed premalignant cervical conditions increases with time since the previous smear, but more than 5 years have to elapse before the risk is comparable with that in first smears taken. Postmenopausal women without previous smears run the highest risk of serious cervical premallgnancies and cancer. Several risk factors have been noted for cervical premalignancies and cervical cancer.
Detection and treatment of cervical intra-epithelial neoplasia (CIN) is an established method of secondary prevention of squamous cell carcinoma of the uterine cervix. Many countries have systematized this in mass screening programmes, with vaginal smears (Pap smears) as the screening test. Until 1992, Norway had no such screening programme. Nevertheless, there has been a widespread and increasing use of Pap smears over the last 20-25 years. The majority of smears are, however, taken from young women. Older women are less frequently tested. Several risk factors have been noted for cervical premalignancies and cervical cancer. 213 Some of them are human papillomavirus (HPV) infections, 4ti previous dyskaryotic smears 6 and the diagnosis of CIN. Women with these risk factors should be followed up routinely. As the main objectives of a screening programme for cervical cancer are to detect precursors for disease and early cancer in women without known major risk factors, we believe it is important to evaluate the risk of having smears indicating CIN and cancer in these women. Two variables of obvious interest are the age of the woman and the period elapsed since the last negative smear. It is the aim of the present study to evaluate this risk. The study population includes the results of more than 58 000 smears from 40 000 women without previously noted positive smears in a population with frequent Pap smear testing, but no organized screening programme.
MATERIALS AND METHODS
A computerized registration system was established in 1977 at the Department of Pathology at the University Hospital of Troms0. All cytological and histological samples ever examined in the laboratory are registered. The activity goes back to 1973 and covers the pathology service in the two northernmost counties of Norway, Finnmark and Troms. Since 1981 Since -1982 , virtually all histological and cytological specimens from these counties are examined by this laboratory. The system has been operating with an automatic call for follow-up smears in the case of positive or suspicious cytological diagnoses. No data are registered which give the indication for the smear, whether this is an investigation of gynaecological symptoms or a smear taken as part of a routine gynaecological examination.
For our purpose, all smears registered in the period 1979-1990 were successively categorized as either first smear, follow-up smear or smear from repeated opportunistic testing, respectively. Smears from women with no previously registered smear since 1973 were defined as first smear (smear of entry into the registry). Cytological diagnosis of cervical intraepithelial neoplasia, malignant cells, herpes simplex or HPV infections and benign diagnosis accompanied by a recommendation of follow-up, were classified as positive smears and subsequent testing as follow-up smears. Smears from women with no previously registered positive or suspicious smears were regarded as the result of opportunistic testing.
During the 3-year period 1988-1990 a total of 80 191 smears from 47 754 women were investigated at the laboratory. Of these, 7209 women (15%) were eliminated due to previously registered positive smears in the registry, leaving 58 271 smears from 40 536 women aged 13-100 years (mean age 36 years) for this study.
Smears with premalignant cytological diagnoses were classified in two levels, CIN I-II and C1N III, as we were not able to fully differentiate between CIN I and CIN II due to the diagnostic nomenclature used. Time since last smear was calculated for women with a previous negative smear. In the analysis, this interval is given in four categories: «12 months, 13-35 months, 36-59 months and s=60 months (5 years) since the last smear. Age was defined as age at the first smear taken in the period and the analyses were performed in 10-year age groups.
Statistics
Differences between proportions were tested using % 2 test. Trends were tested with the x 2 test for linear trend. Odds ratios (OR) and 95% confidence intervals (CI) for the risk of CIN I-II or CIN III by age and time since last smear were calculated by logistic regression in a model with age in 10-year age groups and time since last smear in four levels as the two independent variables. The analyses were performed with one model consisting of all 58 271 smears and one model based on the result of the first smear registered in the period 1988-1990 for the 40 536 women. All computations were done after the exclusion of women with a more serious diagnosis, i.e. elimination of women with CIN III and cancer, for calculations of OR for CIN I-II. Odds ratios for cancer in smears were only computed for women aged s»50 since this diagnosis was not found in smears from younger women. Data were analysed with SAS. 7 Table 1 gives the number of smears by age of the women and the relation between age and time since last smear. There was a U-shaped relationship between age and the proportion of smears from women registered for the first time, with the highest proportion in smears from young women. Among women with two or more registered smears since 1973, there was a direct relationship between age and time since the last negative smear. About 27% of the smears from women aged 50-69 years were taken for the first time or after a period of S5 years since last negative smear, compared to 17% from women 30-49 years of age (P < 0.001). In women with two or more smears, about 60% of all smears were taken within a 3-year period.
RESULTS
In women aged 20-29 years CIN I-II was found in 1.1% of the 18 581 smears and CIN III was found in 0.1% of smears from the women in this age group. However, CIN III was most frequent in smears from women >70 years (0.4%). In 10 412 smears from women with no previously registered smear, CIN I-II and CIN HI were found in 1.1% and 0.3% of the smears, respectively. Crude OR for CIN and OR adjusted for age or time since last smear are presented in Table 2 .
Odds ratio for CIN I-II decreased with age for women aged &20 years. Controlling for age, the OR for CIN I-II was highest in smears taken after an interval of 3*5 years, similar to the risk in first registered smears. Odds ratio for the diagnosis of CIN III increased with age and was highest in women aged s»70 (/"-value for trend < 0.001). A very low risk was found in the youngest women. Adjusted for age, the OR for CIN III was lower overall in smears from women with previously registered smears than in smears from women registered for the first time. However, the OR increased with time since last smear. Only in smears taken after an interval of 3=5 years was the OR not statistically significantly lower than for CIN III in first registered smears. The same analysis in a model consisting of only women 3=50 years, and presumably postmenopausal, revealed very low OR estimates for women who ever had a smear taken and increased with time elapsed (Table 3) .
A total of 16 women had a malignant cytological diagnosis. Mean age at detection was 66.2 years; the youngest woman was 55 years old. Crude OR for smear indicating cancer increased with age. When adjusting for time since last negative smear, however, no statistically significant difference was found (Table 3 ). For nine of the 16 women, the cancer indication was given in their first registered smear. Five women had their last negative smear S*5 years prior to the smear indicating malignancy and no smear registered in the interval. Odds ratio for the cytological diagnosis of cancer according to time since last smear is given in Table 3 . Due to only one case, the intervals of =S35 months were pooled together.
When restricting the analyses to the result of the first smear registered during 1988-1990 from each of the 40 536 women tested, the same trends in risk of CIN I-II and CIN III by age and time since the last smear were found.
In women with no positive and one or more negative smears previously, 825 and 6800 smears had to be taken to find one case of cytologically diagnosed CIN III or cancer, respectively. If not tested previously, the numbers of smears to be taken were 325 and 1200 for CIN III and cancer, respectively. These figures are, however, dependent on the age group and are lowest in the oldest age groups. 
DISCUSSION
Our study shows the risk of CIN and cancer in smears from a selected part of a population not submitted to organized mass screening. All smears are from women without registered positive smears previously, and the results do not represent the final diagnosis after histological investigation, nor do they reflect the prevalence of CIN or cancer in all smears taken from the North Norwegian population. However, they reflect the prevalence of CIN and cancer in vaginal smears in women who have either tested negatively previously or have no earlier registered smears. A small number of women have probably had smears investigated by other laboratories before moving into the geographical region of Troms and Finnmark. This is mostly a problem for the age group 20-29 years (e.g. students) which is empirically more mobile than older people. The proportion of first time registered smears may therefore have been slightly overestimated, but we find it unlikely that this has significantly biased the main results of our study.
Previous investigation of reasons for cervical testing has revealed that the majority of Pap smears represent opportunistic testing, 8 i.e. smears taken outside an organized programme in the absence of genital symptoms. However, clinical symptoms are probably more often the reason for vaginal smears in older age groups than in the younger. Women aged 50-69 years had a relatively low proportion of first time registered smears, but the highest risk of having CIN III or cancer diagnosed in smears of that category. A surprisingly high prevalence of CIN was found in smears from women aged ^70 in our study. A high proportion, about 30% of all smears taken in this age group, were smears registered for the first time. The prevalence of CIN and cancer in smears from postmenopausal women in organized screening should therefore be expected to be lower than the prevalence found in this study.
In our study, many women contribute more than one smear (mean 1.44 smears), and a bias may have been introduced as the results from two smears are not independent. However, our results were essentially the same when only the first smear in the time period 1988-1990 from each woman was included in the analyses.
The cytological diagnosis of CIN was given in all age groups. The risk varied with age and interval since the last negative smear. Consistent with knowledge of the natural history of the disease, CIN I-II is most frequently diagnosed in young women.
9 - 10 In our study, the risk was highest in women 20-29 years, whereafter the risk decreased. The risk for CIN III was very low in young women («19 years) and, compared to women 20-29 years old, statistically significantly increased in women aged 2*30.
The risk of CIN III was significantly higher in women with no previous cervical smear than in women with <5 years since last negative smear. This was particularly true for women aged 5=50 and could indicate that CIN III only rarely develops de novo in postmenopausal women." Several authors emphasize the importance of including postmenopausal women not tested for the last 10-12 years in a screening programme until the age of 70-75 years. 12 " 15 However, continuous screening after the age of 50 of women with a prior screening history of regular negative smears contributes only marginally to the reduction of cervical cancer incidence," with a high cost-benefit ratio. 15 As expected, we found an increasing risk of CIN with increasing intervals since the last negative smear. This has been documented before, 1617 although to our knowledge not in a population without previously noted abnormal smears.
The OR estimates for the cytological diagnosis of cancer are based on few cases. Thus, the CI are very wide and should be interpreted with caution. However, the majority of the cases with a malignant cytological diagnosis were detected in women without previously registered smears, and, although the final and histologically verified diagnoses for these women are not included in our study, the results indicate that women in this category are at the highest risk for developing cancer of the cervix.
Knowledge about the risk of cancer and CIN at different intervals after a negative smear is important when planning a mass screening programme.
l8 -19 Frequent screening at low risk leads to a high cost-benefit ratio, and undesirable side effects, such as an increased risk of false-positive tests. However, long screening intervals imply an increased risk for rapidly progressing cancers (interval cancers) which would surface clinically at unfavourable stages. The decision about the screening interval has to take into account these factors. The Norwegian screening programme includes women aged 25-70 years with recall every third year. 20 Our study shows that this interval may be appropriate. Only in smears taken after an interval of s*5 years, was the risk of CIN not significantly reduced compared to the risk of CIN in smears taken for the first time.
Our material does not include the results of histological investigations following the positive smears as our primary aim was to study the prevalence of women with cytological ly detectable cervical pathology according to the interval since the last negative smear. Mostly women with pathology in Pap smears are referred for further investigation and treatment, thus knowledge about the prevalence of cytologically detectable malignancy and premalignancy is important when planning a screening programme. However, data about the test validity are necessary to evaluate the results of spontaneous Pap testing on the incidence of CIN and cervical cancer in the population.
In summary, we found that the risk of diagnosing CIN and cancer in smears increases with time since the last negative smear, and women with no previous smear run the greatest risk. This is most pronounced in postmenopausal women. The absolute risk of CIN I-III and cancer is, however, low after previous negative smears. Our study shows the importance of testing postmenopausal women never or rarely tested. If the women are told not to disregard relevant symptoms in the screening interval, an interval of 3 years seems appropriate.
